The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $101.99

Today's change0.00 0.00%
Updated March 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $101.99

Today's change0.00 0.00%
Updated March 26 4:00 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp closed at (U.S.)$101.99.

Shares have lost 1.31% over the last five days, but sit 3.29% below their 52-week high. This security has outperformed the S&P 500 by 24.46% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $101.99
  • High--
  • Low--
  • Bid / Ask(U.S.) $101.34 / (U.S.) $105.39
  • YTD % change+5.90%
  • Volume0
  • Average volume (10-day)4,959,857
  • Average volume (1-month)4,251,220
  • Average volume (3-month)4,547,338
  • 52-week range(U.S.) $72.37 to (U.S.) $105.46
  • Beta1.05
  • Trailing P/E25.67×
  • P/E 1 year forward19.76×
  • Forward PEG1.33×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.37%
  • Trailing EPS(U.S.) $3.97
Updated March 26 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.33%

Based on its net profit margin of 3.33%, CVS Health Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue37,05535,02134,60232,689
Total other revenue--------
Total revenue37,05535,02134,60232,689
Gross profit6,6336,4686,3245,942
Total cost of revenue30,42228,55328,27826,747
Total operating expense34,73433,29632,39430,665
Selling / general / administrative4,3124,2224,1163,918
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0521----
Other operating expenses, total--------
Operating income2,3211,7252,2082,024
Interest income (expense), net non-operating-135-158-161-161
Gain (loss) on sale of assets--------
Other--------
Income before tax2,1901,5722,0501,866
Income after tax1,3229481,2461,129
Income tax, total868624804737
Net income1,3219481,2461,129
Total adjustments to net income--------
Net income before extra. items1,3229481,2461,129
Minority interest0------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3229481,2461,129
Inc. avail. to common incl. extra. items1,3219481,2461,129
Diluted net income1,3219481,2461,129
Dilution adjustment--------
Diluted weighted average shares1,1511,1641,1741,190
Diluted EPS excluding extraordinary itemsvalue per share1.150.811.060.95
Dividends per sharevalue per share0.280.280.280.28
Diluted normalized EPSvalue per share1.151.081.060.95